NAS receives non-compliance notice from Nasdaq

TriMed Staff | | Health Imaging | Screening

Nasdaq has indicated that North American Scientific (NAS) has failed to regain compliance with the minimum $1 bid price per share requirement within the 180 calendar-day compliance period, which ended April 2.

Nasdaq also noted that the Chatsworth, Calif.-based NAS is not eligible for an additional 180 calendar-day compliance period given that it does not meet the Nasdaq capital market initial inclusion criteria of $15 million market value of publicly held shares.

Therefore, the company's common stock is subject to delisting from the Nasdaq capital market at the opening of business on April 15. 

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.